VIDEO: 10 Marijuana Megatrends for 2023 and Beyond

Welcome to my Weekly Weed Report for Thursday, September 29. The article below is a condensed transcript; the video contains further details and several charts.

We’re in a volatile bear stock market right now, but one of the shrewdest and surest ways to make money is to pinpoint investment “megatrends” that will unfold over the long term, regardless of whether we’re in a bull or bear market, an economic expansion or recession.

Which begs the question: What will be the megatrends for the marijuana industry in 2023? Here’s what my research tells me.

1. Cannabis Sales Will Rapidly Grow

Several legalization measures are on state ballots for the forthcoming midterm elections in the U.S.; most of these initiatives are heavily favored to pass. As the number of legal markets grows, so will sales.

Also fueling sales will be greater social and political acceptance of formerly demonized cannabis.

2. More “Red States” Will Legalize Marijuana

Adult-use (i.e., recreational) marijuana is legal for adults in 19 states and Washington, DC. Medical marijuana is legal in 38 states and DC.

The stalwart pot prohibitionists, most of whom live in culturally conservative, Republican-dominated states, will be forced to capitulate.

During the November midterms in the U.S., referenda on pot normalization will occur in many states where weed is illegal, and polls in those states show that majorities of the voting public favor the change.

There are proposed adult-use ballot initiatives in Arkansas, North Dakota, Ohio, and South Dakota. Similarly, there are both adult-use and medical ballot measures proposed in Florida, Idaho, Missouri, Nebraska, and Oklahoma.

3. There Will Be a Proliferation of New Cannabis Products

We’ll see cannabis become even more of a mainstream consumer product, with the introduction of a wide variety of marijuana-infused products, including new “flower” strains, vapes, edibles, beverages, foods, cosmetics, you name it.

We’ll especially see fast growth in edibles and beverages, infused with either THC or CBD. The retail shelves of America will be invaded with a panoply of innovative offerings and brands.

4. Consumers Will Be More Demographically Diverse

We’re likely to see more senior citizens embrace pot use, as well as a growing number of females. Another unfolding trend is the adoption of recreational use by consumers who are currently strictly on the medical side, as social taboos against marijuana continue to fall by the wayside.

5. Biotech Marijuana Companies Will Launch Breakthrough Medicines

Medical marijuana use is poised to soar in 2023. Several companies with cannabis-related medical treatments in the developmental pipeline are receiving favorable results so far in clinical trials.

These medicines are on the cusp of FDA approval and introduction into society, leading more doctors to prescribe medical marijuana.

6. Synthetic Cannabis Will Enjoy Exponential Demand

The race for “Cannabis 2.0” has been heating up and it’s poised to be one of the most disruptive trends in the marijuana industry in 2023 and in the years to come.

Big Pharma has made huge strides in recent months to “medicalize” cannabis. That is, mainstream biotech companies are synthetically creating cannabis compounds in the lab that perform just like medicine.

7. Big Tobacco Will Increasingly Join Forces With Pot Companies

Tobacco companies will accelerate their involvement with the cannabis industry. As legal restrictions against marijuana are increasingly removed, tobacco companies will acquire or make large stakes in marijuana companies, to tap into the mainstreaming of pot and also to make up for declining tobacco cigarette sales.

8. Ditto for Big Pharma

Pot legalization has been cutting into the sales, profits, market share, and stock prices of giant drugmakers, which is why these cash-rich behemoths have lobbied against lifting cannabis restrictions. However, their efforts at stopping “the green rush” have met with scant success.

Hence, we’re seeing “Plan B” unfold, whereby Big Pharma resorts to co-opting the unstoppable marijuana megatrend, through mergers and acquisitions and other forms of direct investment

9. Europe Will Emerge as The #1 Marijuana Market

With a population of more than double that of the United States and Canada combined, Europe is set to become the world’s largest legal cannabis market.

North America currently dominates, but that should change next year as more and more European countries legalize weed. Across Europe, with a population of 748 million and an annual health care spend exceeding €2.1 trillion (EUR), the expectation is that the Continent will become the largest world market for cannabis.

10. Marijuana Companies Will Get More Involved in Psychedelics

Big Pharma is plowing considerable resources into researching psychedelics, helping pull these drugs into the pharmaceutical mainstream.

Marijuana companies already are jumping aboard the bandwagon, with research investments in LSD, psilocybin mushrooms, and other psychedelic substances with proven medical and psychological benefits. This trend will gather steam as restrictions against psychedelics are lifted in a growing number of jurisdictions.

Editor’s Note: The data I’ve just presented show that marijuana is becoming a commonplace consumer product around the world.

Although it’s hard to say whether federal legalization will happen in the U.S. in 2023, it’s only a matter of time before Congress finally lifts restrictions against weed. This seismic event would unleash a tsunami of marijuana profits. In the meantime, state-level legalization will definitely accelerate next year, creating huge new markets.

To get ahead of the curve, I urge you to read my new book: The Wide World of Weed and Psychedelics. The product of years of painstaking research, my book is now available for sale. Click here to order your copy.

John Persinos is the editor-in-chief of Marijuana Investing Daily. You can reach him at: mailbag@investingdaily.com

Subscribe to his video channel: